Table 3.
Variable | 2 weeks | 3 months | 6 months | ||||||
---|---|---|---|---|---|---|---|---|---|
|
|
|
|||||||
TVT-O (n=64) | TVT-A (n=78) | P-value | TVT-O (n=58) | TVT-A (n=72) | P-value | TVT-O (n=47) | TVT-A (n=56) | P-value | |
Groin pain | 8 (12.5) | 8 (10.3) | 0.791 | 0 (0.0) | 1 (1.4) | 0.999 | 0 (0.0) | 0 (0.0) | 0.999 |
| |||||||||
Urinary retention | 3 (4.7) | 4 (5.1) | 0.999 | 1 (1.7) | 1 (1.4) | 0.999 | 0 (0.0) | 2 (3.6) | 0.499 |
| |||||||||
Mesh exposure | 1 (1.6) | 0 (0.0) | 0.451 | 0 (0.0) | 0 (0.0) | 0.999 | 1 (2.1) | 0 (0.0) | 0.456 |
| |||||||||
VVF | 0 (0.0) | 0 (0.0) | 0.999 | 0 (0.0) | 0 (0.0) | 0.999 | 0 (0.0) | 0 (0.0) | 0.999 |
Values are presented as number (%).
TVT-O, tension-free vaginal tape-obturator®; TVT-A, tension-free vaginal tape-Abbrevo; VVF, vesicovaginal fistula.